COMPARATIVE STUDY ON THE MEASUREMENT OF LIVER T2* VALUES OF THALASSEMIA PATIENTS AND THE CLINICAL GRADING OF LIVER IRON CONCENTRATION BY DIFFERENT POST-PROCESSING SOFTWARE
Objective: To explore the relationship between the liver T2* values of thalassemia patients measured by Circle Cardiovascular Imaging CVI42 (CVI42), CMRtools / Thalassemia Tools (CMRtools) and Excel spreadsheet (Excel), and the three software's accuracy in clinical grading of liver iron concen...
        Saved in:
      
    
          | Main Authors: | Peng Peng, Fengming XU, Jixing YI, Bumin LIANG, Cheng TANG, Qing FENG | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | PAGEPress Publications
    
        2022-10-01 | 
| Series: | Mediterranean Journal of Hematology and Infectious Diseases | 
| Subjects: | |
| Online Access: | http://mjhid.org/index.php/mjhid/article/view/5033 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    COMPARATIVE STUDY ON THE MEASUREMENT OF LIVER T2* VALUES OF THALASSEMIA PATIENTS AND THE CLINICAL GRADING OF LIVER IRON CONCENTRATION BY DIFFERENT POST-PROCESSING SOFTWARE        
                          
 by: Peng Peng, et al.
 Published: (2022-10-01)
- 
                
                    SEVERE LIVER IRON CONCENTRATIONS (LIC) IN 24 PATIENTS WITH Β-THALASSEMIA MAJOR: CORRELATIONS WITH SERUM FERRITIN, LIVER ENZYMES AND ENDOCRINE COMPLICATIONS        
                          
 by: Vincenzo De Sanctis
 Published: (2018-10-01)
- 
                
                    DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA        
                          
 by: Ali Taher
 Published: (2018-11-01)
- 
                
                    Comparative study of efficacy of different iron chelating agents in treatment of iron overload in children with Beta Thalassemia Major        
                          
 by: adel abd elhaleim hagag
 Published: (2014-08-01)
- 
                
                    LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING        
                          
 by: Jassada Buaboonnam, et al.
 Published: (2021-10-01)
 
       